Submassive liver necrosis in a hepatitis B carrier with Cushing's syndrome

Journal of the Formosan Medical Association

Volumn 101, Issue 2, 2002, Pages 156-158

  Tsou, Pei Ling ^a   Lee, Hsuan Shu ^a   Jeng, Yung Ming ^a   Huang, Tien Shang ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Cushing's syndrome; Hepatitis B; Immunosuppression; Lamivudine

Indexed keywords

HEPATITIS B ANTIGEN; HEPATITIS B CORE ANTIGEN; IMMUNOSUPPRESSIVE AGENT; KETOCONAZOLE; LAMIVUDINE; NUCLEOSIDE ANALOG;

ADRENAL CORTEX ADENOMA; ADRENALECTOMY; ADULT; ANTIGEN DETECTION; ARTICLE; AUTOPSY; BLOOD CLOTTING DISORDER; CASE REPORT; CELL MEMBRANE; CELL NUCLEUS; CUSHING SYNDROME; CYTOPLASM; DEATH; DISEASE CARRIER; DISEASE SEVERITY; DOSE RESPONSE; EARLY DIAGNOSIS; HEPATITIS B; HUMAN; HUMAN TISSUE; HYPERCORTISOLISM; IMMUNOSUPPRESSIVE TREATMENT; LIVER CELL; LIVER FAILURE; LIVER FUNCTION; LIVER NECROSIS; LIVER NODULE; LIVER REGENERATION; LIVER TOXICITY; MALE; PATIENT MONITORING; SCREENING TEST; SEPTICEMIA; TAIWAN;

ADULT; CARRIER STATE; CUSHING SYNDROME; FATAL OUTCOME; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER; MALE; NECROSIS;

EID: 0036306548     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Adrenal gland
2. Opportunistic infections in endogenous Cushing's Syndrome
3. Fulminant hepatic failure in leukemia and choriocarcinoma related to withdrawal of cytotoxic drug therapy
4. Fulminant hepatic failure in non-Hodgkin lymphoma patients treated with chemotherapy
5. Severe clinical rebound upon withdrawal of corticosteroid before interferon therapy: Incidence and risk factors
6. Lamivudine treatment of advanced and decompensated liver disease due to hepatitis B
7. The treatment of chronic viral hepatitis
8. Lamivudine treatment is beneficial in patients with severely decompensated cirrhosis and actively replicating hepatitis B infection awaiting liver transplantation: A comparative study using a matched, untreated cohort
9. Results on preemptive or prophylactic treatment of lamivudine in HBsAg (+) renal allograft recipients: Comparison with salvage treatment after hepatic dysfunction with HBV recurrence
10. Successful use of lamivudine for severe acute hepatitis B virus infection in a cardiac transplant recipient
11. A possible role for lamivudine as prophylaxis against hepatitis B reactivation in carriers of hepatitis B who undergo chemotherapy and autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma
12. Reactivation of chronic hepatitis B infection following intensive chemotherapy and successful treatment with lamivudine: A case report and review of the literature
13. Reactivation of chronic hepatitis B virus infection by cancer chemotherapy
14. HLA class I antigen display on hepatocyte membrane in chronic hepatitis B virus infection: Its role in the pathogenesis of chronic type B hepatitis
15. Hepatitis B virus DNA contains a glucocorticoid-responsive element